poster session 9



nr. title 1st


P159 Intrauterine devices and severe pelvic inflammatory disease require hospitalization

V. Kova (Slovenia) abstract
P160 Pelvic actinomycosis. A comparison of three recent cases with the literature

A. Baird (UK) abstract
P161 Hormonal contraception in women with diabetes mellitus: a review of the literature

J Shawe (UK) abstract
P162 Effects of the continuous use of a combination of ethinyl-estradiol/gestodene in the control of

symptoms reported during the hormone-free interval

R.B. Machado (Brazil) abstract
P163 Metabolic effects of the continuous use of an oral contraceptive containing ethinyl-estradiol and


R.B. Machado (Brazil) abstract
P164 Bleeding patterns in users of a continuous contraceptive combination containing ethinyl-estradiol and


R.B. Machado (Brazil) abstract
P165 Effect of contraception on depression: comparison of Edinburgh and Beck depression scales

K. Ertopçu (Turkey) abstract
P166 Effect of subdermal contraceptive implant (Implanon1) on biochemical serum parameters

M.Inal (Turkey) abstract
P167 Effect of subdermal contraceptive implant (Implanon1) on hormonal parameters

M. Inal (Turkey) abstract
P168 The research of the gonadotropic hormones and prolactin levels in young women while using lowdosed

combined oral contraceptives

L.V. Suturina (Russia) abstract
P169 A non-contraceptive use of the levonorgestrel-releasing intrauterine system: management of

endometrial hyperplasia

Z. Sgarbura (Romania) abstract
P170 Management of contraception in women post organ transplant on tacrolimus – case report and

literature review

A. Brockmeyer (UK) abstract
P171 Evaluation of the SHT470 FA (30 mcg of ethinylestradiol and 3 mg of drospirenone) on contraceptive

efficacy, tolerance, cycle control and effects on general well being and fluid-related symptoms in

women seeking contraception and with premenstrual disorders

A.F. Camargos (Brazil) abstract
P172 A survey of postnatal contraception in opiate-using women

C. Sinha (UK) abstract
P173 Treatment of endometriosis with Implanon versus GnRH agonists: effect on insulin sensitivity

A. Cagnacci (Italy) abstract
P174 Type of progestogen in combined oral contraceptives and risk of myocardial infarction

P. O’Brien (UK) abstract
P175 Experience with Tri-Merci used for combined therapy of cervical intraepithelial neoplasia in patients

with hyperandrogenia

A.A. Sukhanova (Ukraine) abstract
P176 The breast tenderness during using transdermal contraception with evening primrose oil and vitamin E

A. Korenek (Czech Republic) abstract
P177 Tuboovarian abscess associated with an intrauterine device: report on three cases

A. Pretnar-Darovec (Slovenia) abstract
P178 Effects of a monthly injectable contraceptive (Cyclofem) on menstrual pattern and lipoprotein profile

F. Ramezani Tehrani (Iran) abstract
P179 Endometrial morphology and bleeding patterns in Mirena1 users

F. Martinez (Spain) abstract
P180 The case of the missing implant: the importance of adhering to insertion guidelines

U. Ernst (Germany) abstract

Scroll to Top